Welcome to The Exchange Blog Empowering NPs & PAs with Advanced Healthcare Perspectives

Stay ahead in the evolving world of healthcare with The Exchange, a blog for Nurse Practitioners (NPs) and Physician Associates (PAs). Explore invaluable insights curated from NPs and PAs, offering thought-provoking commentaries on essential topics for your practice. From evolving guidelines to career-oriented advice, The Exchange provides the latest and most important perspectives. Sign up to access important healthcare trends and advice, empowering you to navigate the healthcare landscape confidently.

Women in Oncology

As a nurse practitioner, I practice in a predominantly female profession. However, I have seen a wave of symposia at rec ...

Filed under: Health Policy and Trends, Oncology/Hematology, Practice Management/Career


Continue Reading

Can Robots Read Your CT Scan?

At a plenary session of the World Conference on Lung Cancer in September, 2019, in Barcelona, Spain, Hugo Aerts, PhD pre ...

Filed under: Miscellaneous, Oncology/Hematology


Continue Reading

Hydroxychloroquine Monitoring: A Common Drug Seen ...

Hydroxychloroquine (Plaquenil) has been a staple for treatment of rheumatoid arthritis, systemic lupus erythematosis (SL ...

Filed under: Rheumatology


Continue Reading

An Updated Cochrane Review: Can Exercise Reduce Fa ...

We all know how devastating falls can be in our older patients. I send many to physical therapy specifically for fall p ...

Filed under: Miscellaneous, Orthopedics


Continue Reading

Left Main Coronary Artery Occlusion: ST Elevation ...

During my ECG training, we were taught that the findings from lead aVR were only important for supportive evidence of pe ...

Filed under: Cardiometabolic


Continue Reading

The "HINTS" Examination in Vertigo

Vertigo is a symptom, not a diagnosis. It presents a unique problem for many clinicians because it is symptomatic of a p ...

Filed under: Miscellaneous, Neurology


Continue Reading

How Have Carcinogens Tainted Our Generic Drug Supp ...

In July 2018, the FDA announced that a known carcinogen, called N-Nitrosodiumdimethylamine, or NDMA, had been found in v ...

Filed under: Health Policy and Trends, Public Health


Continue Reading

FDA Approves First Oral GLP-1 RA

The US Food and Drug Administration has approved semaglutide (Rybelsus, Novo Nordisk) as the first oral glucagon-like pe ...

Filed under: Miscellaneous


Continue Reading

The Real Risks of Vaping: All Clinicians Must Ask ...

Most of us have seen the recent news regarding the alarming rise of respiratory-related illnesses and deaths due to e-ci ...

Filed under: Health Policy and Trends, Substance Abuse


Continue Reading

Sign up to receive posts from The Exchange